STARGARDT-LIKE MACULAR DYSTROPHY
Clinical trials for STARGARDT-LIKE MACULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new STARGARDT-LIKE MACULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for STARGARDT-LIKE MACULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye disease mystery: new study tracks rare vision loss over years
Knowledge-focused Recruiting nowThis study follows people aged 10 and older with Stargardt-like macular dystrophy (STDG3) caused by ELOVL4 gene changes. Over three years, researchers will track vision and retinal health using eye exams, imaging, and light tests. The goal is to learn how the disease progresses n…
Matched conditions: STARGARDT-LIKE MACULAR DYSTROPHY
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Scientists track eye disease progression in stargardt patients
Knowledge-focused Recruiting nowThis study follows children (over 6) and adults with Stargardt disease or similar inherited eye conditions to see how their vision changes over 2 years. Participants get standard eye tests every 6 months, but no new treatment is given. The goal is to better understand how these d…
Matched conditions: STARGARDT-LIKE MACULAR DYSTROPHY
Sponsor: Astellas Pharma Global Development, Inc. • Aim: Knowledge-focused
Last updated May 18, 2026 12:09 UTC